GIP and lipodystrophy: Recent case series and retrospective analyses have also reported on the use of tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist, in adult patients with lipodystrophy presenting with diabetes (74, 75).